Cardio Diagnostics Statistics
NASDAQ: CDIOHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
1.60-0.05 (-3.03%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cardio Diagnostics by the numbers
Cardio Diagnostics has a market capitalization of $4.7 million based on 2.96M shares outstanding. With trailing EPS of $-2.52, Cardio Diagnostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.9% below its 50-day average and 22.9% below its 200-day average.
Average daily trading volume is 26.91K shares, or about $43,064 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CDIO valuation vs. peer median
| Metric | CDIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.74M | $5.46M | -13% |
| Avg. volume | 26.91K | 195.12K | -86% |
Peer median across 8 companies: BMRA, TRIB, VNRX, QCLS, VRAX, IMDX, ICCC, NNNN.
Valuation
- Market cap
- $4.74M
- Price / sales (latest FY)
- 319.40
- EPS (TTM)
- $-2.52
- Shares outstanding
- 2.96M
Price and trading
- Previous close
- 1.65
- Open
- 1.68
- Day range
- 1.53 – 1.68
- 52-week range
- 0.97 – 7.91
- Beta
- —
- Volume
- 32.03K
- Average volume
- 26.91K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 4.74M
- Forward Pe
- -6.40
- Eps
- -2.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.91
- Week52 Low
- 0.97
- Avg Volume
- 26,915.00
- Shares Outstanding
- 2.96M
- Ma50
- 1.82
- Ma200
- 2.07
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -79.77%
- Pct From52w Low
- 64.95%